United Kingdom· GB-APID-34547811000001109
Truberzi 100mg tablets
A eluxadoline product containing eluxadoline, registered in United Kingdom by Allergan Ltd. The same ATC class is registered in 5 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eluxadoline is registered in 5 of 19 countries.
Countries holding a registration under ATC A07DA06 (eluxadoline), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 3 of them publish a price we can compare per daily dose
Eluxadoline · ATC A07DA06
5 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of eluxadoline costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Eluxadoline · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- US United States$65.57 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eluxadoline
- Manufacturer
- Allergan Ltd
- Country
- United Kingdom (GB)
- ATC code
- A07DA06
- ATC class
- Eluxadoline
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5016007205732
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
244 interactions on record for eluxadoline.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eluxadoline · interactions on record
244 records
- 25 severe
- 218 moderate
- 1 minor
Most severe, free to view
- EltrombopagB02BX05severe
- EthanolB05XX04severe
- GemfibrozilC10AB04severe
- RifampicinJ04AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eluxadoline in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d70b691-07d3-4106-9649-d061d562f04c GET /v1/drugs/1d70b691-07d3-4106-9649-d061d562f04c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34547811000001109",
"desc": "Truberzi 100mg tablets (Allergan Ltd)",
"form": "Oral tablet",
"vpid": "34585311000001104",
"source": "dmd",
"vtm_id": "775746007",
"strength": "100 mg",
"substance": "Eluxadoline",
"ingredient": "Eluxadoline",
"supplier_code": "2062301000001104"
}See everything about eluxadoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.